Life sciences software & AI news

Showing 1000+ results

Oct 22, 2026

Lyric Health Introduces Grace, a Multimodal AI Intelligence Layer Across its Virtual Care Operating System

Integrated into Lyric's Virtual Care Operating System, Grace combines intelligent member engagement, proactive health monitoring, clinical assistance, and automated care coordination to turn healthcare intelligence into actionable outcomes.MCKINNEY, Texas, Oct. 22, 2026 /PRNewswire/ -- Lyric Health, a leading provider of virtual-first healthcare technology and services, today announced the launch of Grace, its AI-powered healthcare companion and intelligence layer designed to transform how healt

A flat illustration of a patient record file with a heart symbol, symbolizing clinical context in health systems.

Oct 22, 2026

When health systems merge EHRs, clinical context is on the line

The consolidation of Electronic Health Records (EHRs) in health systems presents both opportunities and challenges, particularly in preserving the clinical context of patient histories.As health systems pursue EHR consolidation, the approach taken—whether a big-bang or phased rollout—significantly impacts the continuity and accessibility of patient information. A big-bang approach offers immediate integration across all facilities, allowing for a unified patient record. However, this method conc

Oct 22, 2026

Press release

Phylo's Biomni Lab to expand the use of AI agents in scientific research at Bayer

SOUTH SAN FRANCISCO, Calif., Oct. 22, 2026 /PRNewswire/ -- Phylo, Inc. announced today a partnership with Bayer to deploy Biomni Lab, Phylo's agentic AI platform to accelerate scientific research and evaluation. Under the agreement, Phylo will provide Bayer with full access to its agentic platform that helps Bayer scientists bring together scientific literature, biomedical data, and analytical methods in one environment, reducing the manual effort required to assemble and assess evidence. The pl

Oct 22, 2026

Press release

Tsingke Customer Quality Audit Highlights Manufacturing Systems and Quality Controls

BEIJING, Oct. 22, 2026 /PRNewswire/ -- As synthetic biology expands into new applications, standardized manufacturing, reliable production data, and robust quality management are increasingly important. Tsingke recently hosted an on-site customer quality audit by Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. at its Chengdu manufacturing facility.Audit Reviews Key Manufacturing Quality ControlsContinue Reading The audit covered four key areas:Raw Material Traceability: Review

Oct 22, 2026

Press release

Founded by MIT and Flagship Alum, AI Drug Discovery Company Reflector Bio Emerges from Stealth

New York, NY, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Reflector Bio, founded by MIT-trained computational biologist and early employee at Flagship Pioneering's Cellarity, Yuge Ji, today emerged from stealth with an AI drug discovery model that aims to make precision medicine faster and more affordable. Reflector Bio founder and computational biologist, Yuge Ji. Reflector has built what is, to its knowledge, the largest phenotypic model to date by experimental volume. Its platform has previously b

Oct 22, 2026

Press release

Insilica and ProtoQSAR Integrate ProtoPRED® into ToxIndex to Advance Chemical Safety Assessment

The partnership brings more than 60 ProtoPRED® predictive models to the 150+ computational tools in ToxIndex, supporting faster, more transparent and efficient in silico assessments.ROCKVILLE, Md. and VALENCIA, Spain, Oct. 22, 2026 /PRNewswire/ -- Insilica, Inc., developer of the ToxIndex chemical safety intelligence platform, and ProtoQSAR SL, a computational chemistry company specializing in predictive toxicology, today announced a technology integration and distribution agreement. The integra

Oct 22, 2026

Press release

Aclarion Announces New Real-World Publication: Nociscan® Validated by Strong Agreement with Discography in Diagnosing Painful Lumbar Discs

Study conducted at London Spine Clinic found Nociscan's noninvasive scan successfully identified painful discs, agreeing with discography, the invasive gold standard, in up to 87% of casesNociscan also spared patients the needles, added cost, and recovery time that is often associated with discographyAuthors conclude Nociscan “may, in time, replace provocative lumbar discography” in appropriately selected patientsBolsters the case for physician adoption and payor support for Nociscan BROOMFIELD,

A blood sample and microscope in a dimly lit lab

Oct 22, 2026

Revvity: A Diagnostics Annuity Is Quietly Funding An AI Data Engine

Revvity is positioning itself as a leader in the diagnostics sector by evolving into an AI-driven platform, showcasing significant growth in its diagnostics revenue.Revvity (RVTY) is making notable strides in the life sciences industry, differentiating itself from competitors by focusing on diagnostics rather than relying solely on biopharmaceutical budgets. The company reported an 11% increase in organic revenue from its diagnostics segment, while its software annual recurring revenue (ARR) saw

Minimalist illustration of a diagnostic test tube and biomarker

Oct 22, 2026

Revvity shifts to AI-driven diagnostics, postin...

Revvity is transitioning from a traditional tools company to a diagnostics-centric platform powered by artificial intelligence, showcasing significant growth in its Diagnostics segment.The company reported an 11% organic revenue increase in Diagnostics, alongside mid-20% growth in its software Annual Recurring Revenue (ARR). This positive performance offsets challenges faced in the Life Sciences sector and exits from the Chinese market. Revvity has demonstrated robust operating leverage, achievi

Oct 22, 2026

Press release

Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers

SALT LAKE CITY, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces new data from the ongoing MONSTAR-SCREEN-3 study demonstrating the potential of its whole-genome sequencing (WGS)-based Precise MRD™ platform to support ultra-sensitive molecular residual disease (MRD) detection in patients with resectable colorectal and pancreatic cancers. The findings, which will be presented as part of the

Oct 22, 2026

Press release

Vivalink Powers Translational Medicine Through Continuous Physiologic Monitoring Across Healthcare and Clinical Research

Research at Brigham and Women's Hospital and Ochsner Health demonstrates how continuous physiologic data helps translate clinical research into more actionable patient careContinuous monitoring with wearables addresses a key challenge of translational medicine, allowing for uninterrupted data capture that can detect physiologic changes in a patient's condition.Vivalink's Clinical Intelligence Platform enables automated monitoring, transmission and processing of patient data to help derive clinic

Oct 22, 2026

Press release

Withings and Function Connect Daily Health Measurements with Advanced Lab Testing

Two leaders in connected health integrate Withings' daily measurements with Function's 160+ lab tests and Medical Intelligence for a deeper understanding of your health.BOSTON, Oct. 22, 2026 /PRNewswire/ -- Withings and Function today announced a first-of-its-kind integration between Withings' medical-grade connected devices and Function's health platform to connect daily body measurements with deep lab data, turning isolated data points into a single, comprehensive view of your health.Continue

Back to start
Previous
Page 27 of 84
Next

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Platform

Domains

Services

Legal